AACR-AstraZeneca Immuno-oncology Research Fellowships
April 2, 2019 - Grant recipients must attend the Grants Reception and Dinner to formally accept their grant. Grant funds may be used to support the grantees' registration and attendance at this Annual Meeting.
The AACR-AstraZeneca Immuno-oncology Research Fellowships represent a joint effort to encourage and support postdoctoral or clinical research fellows to conduct immuno-oncology research and to establish a successful career path in this field. The research proposed for funding may be basic, translational, clinical, or epidemiological in nature and must have direct applicability and relevance to the role of the immune system in the development and progression of early-stage and/or locally-advanced (non-metastatic) non-small cell lung cancer.
These fellowships provide two-year grants of $120,000 to support the salary and benefits of the fellow while working on mentored immuno-oncology research focused on early-stage and/or locally-advanced (non-metastatic) non-small cell lung cancer. A partial amount of funds may be designated for non-personnel expenses, such as research/laboratory supplies, equipment, publication charges for manuscripts that pertain directly to the funded project, and other research expenses.
Program Guidelines and Application Instructions are available in PDF format.
Research projects may be basic, translational, clinical, or epidemiological in nature, and must have direct applicability and relevance to the role of the immune system in the development and progression of early-stage and/or locally-advanced (non-metastatic) non-small cell lung cancer.
At the start of the grant term on July 1, 2019, applicants must have completed their most recent doctoral degree within the past five years (i.e., degree cannot have been conferred before July 1, 2014) and work under the auspices of a mentor at an academic, medical, or research institution anywhere in the world.
Applicants must have a doctoral degree (including PhD, MD, DO, DC, ND, DDS, DVM, ScD, DNS, PharmD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree.
Applicants with a medical degree must have completed their most recent doctoral degree or medical residency - whichever date is later - within the past five years.
Employees or subcontractors of a U.S. government entity or for-profit private industry are not eligible. Postdoctoral fellows conducting research in a U.S. government laboratory (e.g., NIH, CDC, FDA, etc.), are not eligible.
Any individual who currently holds an active AACR grant may not apply. Past grantees may apply if they complied with all progress and financial report requirements.
Investigators may submit only one application for the AACR-AstraZeneca Immuno-oncology Research Fellowships but may concurrently apply for other AACR grants. However, applicants are expected to accept the first grant they are awarded. Individuals may accept and hold only one AACR grant at a time.
There are no citizenship or geographic requirements. However, by submitting an application for this grant, an applicant applying from an institution located in a country in which they are not a citizen or a permanent resident assures that the visa status will provide sufficient time to complete the project and grant term at the institution from which they applied.
AACR membership is required. Nonmembers interested in this grant opportunity must submit a satisfactory application for AACR Associate Membership by the application deadline. Nonmembers can apply for membership using the Official Membership Application Form submitted to the AACR with the required documents or apply online. In support of the professional development of early-career investigators, no annual dues are required for Associate membership. Lapsed members can renew their membership through their myAACR account.
AACR requires applicants to submit an online application by 1:00 p.m. U.S. Eastern Time on Wednesday, December 19, 2018, using the proposalCENTRAL website at https://proposalcentral.altum.com.
Program Guidelines and Application Instructions are available in PDF format.